12
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Sex and Gender in Neurodegenerative Diseases

      Submit here before September 30, 2024

      About Neurodegenerative Diseases: 3.0 Impact Factor I 4.3 CiteScore I 0.695 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Prevalence of Epilepsy in Children: Tlalpan, Mexico City, Mexico

      research-article

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The prevalence of epilepsy among a sample of children born in 1966 and investigated when they were 9 years old, was studied in Tlalpan, a sector of Mexico City. The prevalence ratios for epilepsy per 1,000 population were: minimum 18.3, average 42.2 and maximum 44.3. The results are compared with those of three studies in other parts of the Americas, using the same methods. The positive predictive value of the test used to identify epileptics was nearly 20% and its possible use in mass screening programs is discussed. Prevalence ratios for simple febrile convulsions and minimal brain dysfunction are also reported.

          Related collections

          Author and article information

          Journal
          NED
          Neuroepidemiology
          10.1159/issn.0251-5350
          Neuroepidemiology
          S. Karger AG
          0251-5350
          1423-0208
          1983
          1983
          09 December 1983
          : 2
          : 1-2
          : 16-23
          Affiliations
          National Institute of Neurology and Neurosurgery, Mexico, and Faculty of Medicine, National Autonomous University of Mexico
          Article
          110506 Neuroepidemiology 1983;2:16–23
          10.1159/000110506
          2b88938f-d628-4582-b7dc-9463f2ec68fd
          © 1983 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 8
          Categories
          Original Paper

          Geriatric medicine,Neurology,Cardiovascular Medicine,Neurosciences,Clinical Psychology & Psychiatry,Public health
          Minimal brain dysfunction,Prevalence,Epilepsy,Children,Epidemiology,Febrile convulsions

          Comments

          Comment on this article